AMHD Stock Overview

Through its subsidiaries, produces and sells biodiesel. More details

AMHD fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Latest financial reports are more than a year old

Does not have a meaningful market cap ($924)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

HLK Biotech Holding Group, Inc. Competitors

Beta Energy

OTCPK:BTAE.F

US$45.9k

Stratos Renewables

OTCPK:SRNW

US$6.8m

Sky Quarry

NasdaqCM:SKYQ

US$16.9m

Blue Dolphin Energy

OTCPK:BDCO

US$26.0m

Price History & Performance

Summary of share price highs, lows and changes for HLK Biotech Holding Group
Historical stock prices
Current Share Price	US$0.0002
52 Week High	US$0.0002
52 Week Low	US$0.0002
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	0%
5 Year Change	-96.92%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AMHD	US Oil and Gas	US Market
7D	0%	-3.3%	2.2%
1Y	n/a	-10.5%	8.2%

Return vs Industry: Insufficient data to determine how AMHD performed against the US Oil and Gas industry.

Return vs Market: Insufficient data to determine how AMHD performed against the US Market.

Price Volatility

Is AMHD's price volatile compared to industry and market?
AMHD volatility
AMHD Average Weekly Movement	n/a
Oil and Gas Industry Average Movement	7.9%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	4.1%

Stable Share Price: AMHD's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine AMHD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1998	n/a	n/a	www.amelotholdings.com

HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018.

HLK Biotech Holding Group, Inc. Fundamentals Summary

How do HLK Biotech Holding Group's earnings and revenue compare to its market cap?
AMHD fundamental statistics
Market cap	US$924.00
Earnings (TTM)	-US$1.04m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is AMHD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMHD income statement (TTM)
Revenue	US$0
Cost of Revenue	US$180.00k
Gross Profit	-US$180.00k
Other Expenses	US$858.34k
Earnings	-US$1.04m

Last Reported Earnings

Jun 30, 1999

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AMHD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 06:17
End of Day Share Price	2025/03/03 00:00
Earnings	1999/06/30
Annual Earnings	1999/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HLK Biotech Holding Group, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.